Cipla Q2 FY27: PAT ₹789 Cr & Rev ₹7,119 Cr

Metric	Value
Revenue	₹7,119 Cr
Net Profit (PAT)	₹789 Cr

📢 Key Event
Cipla reported Q1 FY27 consolidated revenue of INR 7,119 crores, up 2% YoY.

🔄 What Changed
R&D investment rose 12.3% YoY to INR 486 crores (6.8% of sales); net cash position was INR 9,494 crores.

🔮 What's Next
Sequential growth expected in North America supported by upcoming product pipeline; focus on growing key markets and flagship brands.

💡 Investor Takeaway
The company is gaining traction in key markets with strong branded prescription growth and improved cash generation.

Cipla reported consolidated revenue of INR 7,119 crores for Q1 FY27, up 2% YoY, with One India business delivering 12% YoY growth and chronic mix improving to 60.4%. North America generated $162 million in revenue, while Emerging Markets and Europe grew 5% YoY in USD terms. Net cash stood at INR 9,494 crores, and R&D investment reached INR 486 crores (6.8% of sales).

📄 View Original Announcement (PDF)

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"What is the revenue contribution from One India business?" "How does North America revenue compare to previous quarter?" "What is the projected timeline for new product launches in the US?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 23 July 2026

INFY Infosys Limited Financial Results PNBHOUSING PNB Housing Finance Limited Annual Report BPCL Bharat Petroleum Corporation Limited Financial Results CHAMBLFERT Chambal Fertilizers & Chemicals Limited Financial Results SONACOMS Sona BLW Precision Forgings Limited Financial Results TRU TruCap Finance Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.